drugset / Trial / NCT03758365
Evaluation of the Vasoconstriction Properties of MC2-01 Cream
RandomizedParallel-groupSingle-blindTreatment
Summary
The objective of this trial is to compare the vasoconstriction potential
Timeline
- Start
- 2018-11-05
- Primary completion
- 2018-11-23
- Completion
- 2018-11-23
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Calcipotriene | Other / unclassified | 0.005 % | — |
| Comparator | Desonide | Small molecule | 0.05 % | — |
| Comparator | Hydrocortisone Butyrate | Unknown | 0.1 % | — |
| Comparator | Triamcinolone Acetonide | Other / unclassified | 0.1 % | — |
| Comparator | betamethasone dipropionate | Small molecule | 0.05 % | — |
| Comparator | betamethasone dipropionate | Small molecule | 0.064 % | — |
| Comparator | clobetasol propionate | Small molecule | 0.05 % | — |